Apex Capital Management’s Colgate-Palmolive CL Stock Holding History

Apex Capital Management’s Portfolio CL Stock Details CL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$579K	Hold	8,200	–	–	0.01%	228
2015 Q4	$546K	Sell	8,200 -16	-0.2%	-$1.06K	0.01%	213
2015 Q3	$521K	Buy	8,216 +16	+0.2%	+$1.04K	0.01%	211
2015 Q2	$536K	Hold	8,200	–	–	0.01%	222
2015 Q1	$569K	Hold	8,200	–	–	0.01%	215
2014 Q4	$567K	Hold	8,200	–	–	0.02%	204
2014 Q3	$535K	Hold	8,200	–	–	0.02%	205
2014 Q2	$559K	Hold	8,200	–	–	0.02%	211
2014 Q1	$532K	Hold	8,200	–	–	0.02%	209
2013 Q4	$535K	Hold	8,200	–	–	0.02%	198
2013 Q3	$486K	Hold	8,200	–	–	0.02%	193
2013 Q2	$470K	Buy	+8,200	New	+$487K	0.02%	185

Other funds holding CL

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Apex Capital Management's CL Position: Q1 2016 in Review

Apex Capital Management held its Colgate-Palmolive (CL) position steady in Q1 2016 at 8,200 shares worth $579K. The position accounts for 0.01% of the portfolio, ranked #228.

Apex Capital Management first reported a position in CL in Q2 2013 and has held it in 12 quarters since. 1,262 funds tracked by Wall St. Rank hold CL as of Q1 2016.

Apex Capital Management held 8,200 shares of Colgate-Palmolive worth $579K as of Q1 2016.
Apex Capital Management left its Colgate-Palmolive share count unchanged in Q1 2016.
Colgate-Palmolive made up 0.01% of Apex Capital Management's portfolio in Q1 2016, its #228 holding.
Apex Capital Management first reported a position in Colgate-Palmolive in Q2 2013 and has held it in 12 quarters since.
1,262 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q1 2016.

Based on Apex Capital Management's 13F filing for Q1 2016, filed 27 Apr 2016.